Rosmarinic Acid Induces p56lck-Dependent Apoptosis in Jurkat and Peripheral T Cells via Mitochondrial Pathway Independent from Fas/Fas Ligand Interaction

Journal of Immunology

Volumn 172, Issue 1, 2004, Pages 79-87

  Hur, Yun Gyoung ^a   Yun, Yungdae ^b   Won, Jonghwa ^a  

^a Mogam Biotechnology Research Institute   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; DRUG METABOLITE; FAS LIGAND; PHOSPHOTRANSFERASE; PROTEIN P56; PROTEIN P56 LCK; ROSMARINIC ACID; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL CLONE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; HERB; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE; MONOCYTE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0346734197     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.1.79     Document Type: Article

References (71)

1. Rathmell, J. C., and C. B. Thompson. 2002. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell 109(Suppl.):S97.
2. Li, X. C., T. B. Strom, L. A. Turka, and A. D. Wells. 2001. T cell death and transplantation tolerance. Immunity 14:407.
3. Bennett, M., K. Macdonald, S. W. Chan, J. P. Luzio, R. Simari, and P. Weissberg. 1998. Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science 282:290.
4. Green, D. R., and J. C. Reed. 1998. Mitochondria and apoptosis. Science 282:1309.
5. Kroemer, G., and J. C. Reed. 2000. Mitochondrial control of cell death. Nat. Med. 6:513.
6. Cory, S., and J. M. Adams. 2002. The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2:647.
7. Antonsson, B., S. Montessuit, B. Sanchez, and J. C. Martinou. 2001. Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J. Biol. Chem. 276:11615.
8. Eskes, R., S. Desagher, B. Antonsson, and J. C. Martinou. 2000. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol. Cell. Biol. 20:929.
9. Yang, J., X. Liu, K. Bhalla, C. N. Kim, A. M. Ibrado, J. Cai, T. I. Peng, D. P. Jones, and X. Wang. 1997. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129.
10. Mikhailov, V., M. Mikhailova, D. J. Pulkrabek, Z. Dong, M. A. Venkatachalam, and P. Saikumar. 2001. Bcl-2 prevents Bax oligomerization in the mitochondrial outer membrane. J. Biol. Chem. 276:18361.
11. Han, J., D. Modha, and E. White. 1998. Interaction of E1B 19K with Bax is required to block Bax-induced loss of mitochondrial membrane potential and apoptosis. Oncogene 17:2993.
12. Shim, J. H., H. K. Lee, E. J. Chang, W. J. Chae, J. H. Han, D. J. Han, T. Morio, J. J. Yang, A. Bothwell, and S. K. Lee. 2002. Immunosuppressive effects of tautomycetin in vivo and in vitro via T cell-specific apoptosis induction. Proc. Natl. Acad. Sci. USA 99:10617.
13. Hashimoto, Y., N. Matsuoka, A. Kawakami, M. Tsuboi, T. Nakashima, K. Eguchi, T. Tomioka, and T. Kanematsu. 2001. Novel immunosuppressive effect of FK506 by augmentation of T cell apoptosis. Clin. Exp. Immunol. 125:19.
14. Genestier, L., R. Paillot, S. Fournel, C. Ferraro, P. Miossec, and J. P. Revillard. 1998. Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells. J. Clin. Invest. 102:322.
15. Cohn, R. G., A. Mirkovich, B. Dunlap, P. Burton, S. H. Chiu, E. Eugui, and J. P. Caulfield. 1999. Mycophenolic acid increases apoptosis, lysosomes and lipid droplets in human lymphoid and monocytic cell lines. Transplantation 68:411.
16. Cipriani, B., G. Borsellino, H. Knowles, D. Tramonti, F. Cavaliere, G. Bernardi, L. Battistini, and C. F. Brosnan. 2001. Curcumin inhibits activation of Vγ9Vδ2 T cells by phosphoantigens and induces apoptosis involving apoptosis-inducing factor and large scale DNA fragmentation. J. Immunol. 167:3454.
17. Orban, Z., N. Mitsiades, T. R. Burke, Jr., M. Tsokos, and G. P. Chrousos. 2000. Caffeic acid phenethyl ester induces leukocyte apoptosis, modulates nuclear factor-κB and suppresses acute inflammation. Neuroimmunomodulation 7:99.
18. Dorrie, J., H. Gerauer, Y. Wachter, and S. J. Zunino. 2001. Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells. Cancer Res. 61:4731.
19. Lai, J. H., L. J. Ho, K. C. Lu, D. M. Chang, M. F. Shaio, and S. H. Han. 2001. Western and Chinese antirheumatic drug-induced T cell apoptotic DNA damage uses different caspase cascades and is independent of Fas/Fas ligand interaction. J. Immunol. 166:6914.
20. Ho, L. J., D. M. Chang, M. L. Chang, S. Y. Kuo, and J. H. Lai. 1999. Mechanism of immunosuppression of the antirheumatic herb TWHf in human T cells. J. Rheumatol. 26:14.
21. Kimura, Y., H. Okuda, T. Okuda, T. Hatano, and S. Arichi. 1987. Studies on the activities of tannins and related compounds. X. Effects of caffeetannins and related compounds on arachidonate metabolism in human polymorphonuclear leukocytes. J. Nat. Prod. 50:392.
22. Kelm, M. A., M. G. Nair, G. M. Strasburg, and D. L. DeWitt. 2000. Antioxidant and cyclooxygenase inhibitory phenolic compounds from Ocimum sanctum Linn. Phytomedicine 7:7.
23. Sahu, A., N. Rawal, and M. K. Pangburn. 1999. Inhibition of complement by covalent attachment of rosmarinic acid to activated C3b. Biochem. Pharmacol. 57:1439.
24. al-Sereiti, M. R., K. M. Abu-Amer, and P. Sen. 1999. Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials. Indian J. Exp. Biol. 37:124.
25. Won, J., Y. G. Hur, E. M. Hur, S. H. Park, M. A. Kang, Y. Choi, C. Park, K. H. Lee, and Y. Yun. 2003. Rosmarinic acid inhibits TCR-induced T cell activation and proliferation in an Lck-dependent manner. Eur. J. Immunol. 33:870.
26. 2+-dependent pathways of T-cell antigen receptor-mediated signaling by inhibiting the PLC-γl and ltk activity. Blood 101:3534.
27. Yamane, Y., M. Furuichi, R. Song, N. T. Van, R. T. Mulcahy, T. Ishikawa, and M. T. Kuo. 1998. Expression of multidrug resistance protein/GS-X pump and γ-glutamylcysteine synthetase genes is regulated by oxidative stress. J. Biol. Chem. 273:31075.
28. Martin, S. J., C. P. Reutelingsperger, A. J. McGahon, J. A. Rader, R. C. van Schie, D. M. LaFace, and D. R. Green. 1995. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 182:1545.
29. Lewis L.A., C.D. Chung J. Chen, J. R. Parnes M, Moran V. P. Patel, and M. C. Miceli. 1997. The Lck SH2 phosphotyrosine binding site is critical for efficient TCR-induced processive tyrosine phosphorylation of the ξ-chain and IL-2 production. J. Immunol. 159:2292.
30. Zhu, X., J. L. Kim, J. R. Newcomb, P. E. Rose, D. R. Stover, L. M. Toledo, H. Zhao, and K. A. Morgenstern. 1999. Structural analysis of the lympocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors. Struct. Fold Des. 7:651.
31. Hanke, J. H., J. P. Gardner, R. L. Dow, P. S. Changelian, W. H. Brissette, E. J. Weringer, B. A. Pollok, and P. A. Connelly. 1996. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor: study of Lck- and FynT-dependent T cell activation. J. Biol. Chem. 271:695.
32. lck mediates, both intermolecular and intramolecular interaction. Proc. Natl. Acad. Sci. USA 90:10285.
33. Anto, R. J., A. Mukhopadhyay, K. Denning, and B. B. Aggarwal. 2002. Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis 23:143.
34. Cheng, J., T. Zhou, C. Liu, J. P. Shapiro, M. J. Brauer, M. C. Kiefer, P: J. Barr, and J. D. Mountz. 1994. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263:1759.
35. 2-terminal kinase activation:leads to a FADD-dependent but Fas ligand-independent cell death in Jurkat T cells. J. Biol Chem. 276:8350.
36. Scaffidi, C., S. Fulda, A. Srinivasan, C. Friesen, F. Li, K. J. Tomaselli, K. M. Debatin, P. H. Krammer, and M. E. Peter. 1998. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17:1675.
37. Kroemer, G., N. Zamzami, and S. A. Susin. 1997. Mitochondrial control of apoptosis. Immunol. Today 18:44.
38. Mancini, M., B. O. Anderson, E. Caldwell, M. Sedghinasab, P. B. Paty, and D. M. Hockenbery. 1997. Mitochondrial proliferation and paradoxical membrane depolarization during terminal differentiation and apoptosis in a human colon carcinoma cell line. J. Cell Biol. 138:449.
39. Salvioli, S., A. Ardizzoni, C. Franceschi, and A. Cossarizza. 1997. JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess δψ changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett. 411:77.
40. Zou, H., Y. Li, X. Liu, and X. Wang. 1999. An APAF-1 cytochrome C multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274:11549.
41. L. J. Biol. Chem. 274:2225.
42. Gross, A., J. Jockel, M. C. Wei, and S. J. Korsmeyer. 1998. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 17:3878.
43. Saito, M., S. J. Korsmeyer, and P. H. Schlesinger. 2000. BAX-dependent transport of cytochrome c reconstituted in pure liposomes. Nat. Cell. Biol. 2:553.
44. Slee, E. A., M. T. Harte, R. M. Kluck, B. B. Wolf, C. A. Casiano, D. D. Newmeyer, H. G. Wang, J. C. Reed, D. W. Nicholson, E. S. Alnemri, et al. 1999. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 144:281.
45. Belka, C., P. Marini, A. Lepple-Wienhues, W. Budach, A. Jekle, M. Los, F. Lang, K. Schulze-Osthoff, E. Gulbins, and M. Bamberg. 1999. The tyrosine kinase lck is required for CD95-independent caspase-8 activation and apoptosis in response to ionizing radiation. Oncogene 18:4983.
46. Luciano, F., J. E. Ricci, and P. Auberger. 2001. Cleavage of Fyn and Lyn in their N-terminal unique regions during induction of apoptosis: a new mechanism for Src kinase regulation. Oncogene 20:4935.
47. Lowell, C. A., and P. Soriano. 1996. Knockouts of Src-family kinases: Stiff bones, wimpy T cells, and bad memories. Genes Dev. 10:1845.
48. Rodenburg, R. J., A. Ganga, P. L. van Lent, L. B. van de Putte, and W. J. van Venrooij. 2000. The antiinflammatory drug sulfasalazine inhibits tumor necrosis factor α expression in macrophages by inducing apoptosis. Arthritis Rheum. 43:1941.
49. Grodzicky, T., and K. B. Elkon. 2002. Apoptosis: a case where too much or too little can lead to autoimmunity. Mt. Sinai J. Med. 69:208.
50. Li, X. C., A. D. Wells, T. B. Strom, and L. A. Turka. 2000. The role of T cell apoptosis in transplantation tolerance. Curr. Opin. Immunol. 12:522.
51. Biondi, A., C. Paganin, V. Rossi, S. Benvestito, R. M. Perlmutter, A. Mantovani, and P. Allavena. 1991. Expression of lineage-restricted protein tyrosine kinase genes in human natural killer cells. Eur. J. Immunol. 21:843.
52. Chen, H., Z. S. Zhang, Y. L. Zhang, and D. Y. Zhou. 1999. Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells. Anticancer Res. 19:3675.
53. Mehta, K., P. Pantazis, T. McQueen, and B. B. Aggarwal. 1997. Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines. Anticancer Drugs 8:470.
54. L, NF-κB, and p53. Clin. Immunol. 93:152.
55. Piwocka, K., K. Zablocki, M. R. Wieckowski, J. Skierski, I. Feiga, J. Szopa, N. Drela, L. Wojtczak, and E. Sikora. 1999. A novel apoptosis-like pathway, independent of mitochondria and caspases, induced by curcumin in human lymphoblastoid T (Jurkat) cells. Exp. Cell Res. 249:299.
56. Chung, C. D., L. A. Lewis, and M. C. Miceli. 1997. T cell antigen receptor-induced IL-2 production and apoptosis have different requirements for Lck activities. J. Immunol. 159:1758.
57. Gonzalez-Garcia, A., R. B. L., E. Leonardo, I. Merida, A. C. Martinez, and A. C. Carrera. 1997. Lck is necessary and sufficient for Fas-ligand expression and apoptotic cell death in mature cycling T cells. J. Immunol. 158:4104.
58. Latinis, K. M., and G. A. Koretzky. 1996. Fas ligation induces apoptosis and Jun kinase activation independently of CD45 and Lck in human T cells. Blood 87:871.
59. Schirmer, M., A. N. Vallejo, C. M. Weyand, and J. J. Goronzy. 1998. Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4-CD28-T cells from rheumatoid arthritis patients. J. Immunol. 161:1018.
60. Salmon, M., D. Scheel-Toellner, A. P. Huissoon, D. Pilling, N. Shamsadeen, H. Hyde, A. D. D'Angeac, P. A. Bacon, P. Emery, and A. N. Akbar. 1997. Inhibition of T cell apoptosis in the rheumatoid synovium. J. Clin. Invest. 99:439.
61. Youn, J., K. H. Lee, J. Won, S. J. Huh, H. S. Yun, W. G. Cho, and D, J. Paik. 2003. Beneficial effects of rosmarinic acid on suppression of collagen induced arthritis. J. Rheumatol. 30:1203.
62. Wu, Y. M., C. L. Huang, H. J. Kung, and C. Y. Huang. 2001. Proteolytic activation of ETK/Bmx tyrosine kinase by caspases. J. Biol. Chem. 276:17672.
63. lck is required for ceramide-induced but not tumor necrosis factor-induced activation of NF-κB, AP-1, JNK, and apoptosis. J. Biol. Chem. 275:13297.
64. lck in HIV-tat versus TNF-induced cellular responses: effects on NF-κB, activator protein-1, c-Jun N-terminal kinase, and apoptosis. J. Immunol. 164:5156.
65. Belka, C., C. Gruber, V. Jendrossek, S. Wesselborg, and W. Budach. 2003. The tyrosine kinase Lck is involved in regulation of mitochondrial apoptosis pathways. Oncogene 22:176.
66. Kluck, R. M., E. Bossy-Wetzel, D. R. Green, and D. D. Newmeyer. 1997. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132.
67. Murphy, K. M., U. N. Streips, and R. B. Lock. 2000. Bcl-2 inhibits a Fas-induced conformational change in the Bax N terminus and Bax mitochondrial translocation. J. Biol. Chem. 275:17225.
68. Murphy, K. M., V. Ranganathan, M. L. Farnsworth, M. Kavallaris, and R. B. Lock. 2000. Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells. Cell Death Differ. 7:102.
69. Sun, X. M., M. MacFarlane, J. Zhuang, B. B. Wolf, D. R. Green, and G. M. Cohen. 1999. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J. Biol. Chem. 274:5053.
70. Bellosillo, B., N. Villamor, A. Lopez-Guillermo, S. Marce, F. Bosch, E. Campo, E. Montserrat, and D. Colomer. 2002. Spontaneous and drug-induced apoptosis is mediated by conformational changes of Bax and Bak in B-cell chronic lymphocytic leukemia. Blood 100:1810.
71. Wieder, T., F. Essmann, A. Prokop, K. Schmelz, K. Schulze-Osthoff, R. Beyaert, B. Dorken, and P. T. Daniel. 2001. Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3. Blood 97:1378.